Upper-airway Changes After Bimaxillary Advancement in OSAHS (OSAHS)

February 9, 2021 updated by: Carlos Prol Teijeiro, Hospital de Cruces

Upper-airway Changes After Bimaxillary Advancement in Moderate-severe Obstructive Sleep Apnoea / Hypopnoea Syndrome

One of the most effective surgical treatments for obstructive sleep apnoea / hypopnoea syndrome (SAHS) with global impact on the upper-airway (UA) is the maxilla-mandibular advancement (MMA). Retrospective-prospective observational study of: clinical outcomes, UA and dental-cranium-facial (DCF) morphology.

Population sample will be patients treated in the Maxillofacial Surgery department of "Hospital de Cruces". As inclusion criteria: ≥18 years-old, moderate-severe SAHS in supine position, multidisciplinary committee of sleep pathology evaluation for surgical indication, and written informed consents. As exclusion criteria: pregnant woman, SAHS of central origin, cranium-facial deformities that significantly modify normal UA, different surgery than MMA and inconclusive / incomplete tests. It is estimated ≥90% males; ≥90% 30-59 years-old; ≤10% extreme weights; 25% complementary surgeries; and sample size 40. Medical ethics code of the Declaration of Helsinki will be taken into account. To collect the pre- / postoperative data we will use, calibrated and standardized: polysomnography (PSG), computed tomography (CT), right face profile picture (RFP) and lateral teleradiography of the cranium (LTC). Furthermore, the Epworth scale and non-validated subjective self-perception test of facial aesthetics will be performed.

Clinical outcomes will be evaluated from PSG using apnoea / hypopnoea index and pulse oximeter oxygen saturation, and from Epworth scale. UA morphology from CT, globally and by specific locations, through lengths, volumes, areas, dimensions, and other measurements. DCF aspects from RFP and LTC, by Ricketts cephalometric basic analysis and facial aesthetics test. Statistical, descriptive analysis of frequencies and comparative by pairs of quantitative data will be by t-Student or Wilcoxon test, after checking the variables normality with the Kolmogorov-Smirnov test.

Study Overview

Status

Active, not recruiting

Detailed Description

HYPOTHESIS:

H0: Upper-airway (UA) morphology does not change as a consequence of maxilla-mandibular advancement (MMA) in patients with moderate-severe obstructive sleep apnoea / hypopnoea syndrome (SAHS).

H1: UA changes as a consequence of MMA in patients with moderate-severe SAHS. To answer this hypothesis, the following will be determined: Vertical UA length, volume, axial areas, ellipticity, uniformity, prevertebral soft tissue (PST) and soft palate (SP) lengths and position of the hyoid bone.

As secondary hypotheses:

H0: Clinical outcomes of MMA in moderate-severe SAHS are not successful. H1: Clinical outcomes of MMA in moderate-severe SAHS are successful. To answer, the apnoea / hypopnoea index (AHI), pulse oximeter oxygen saturation (SPO2) and daytime sleepiness will be determined.

H0: DCF morphology is unfavourable as a result of MMA in moderate-severe SAHS. H1: DCF morphology is not unfavourable as a result of MMA in moderate-severe SAHS.

To answer, the parameters of the Ricketts cephalometric basic analysis will be quantified and interpreted, and the patient's self-perception will be assessed.

OBJECTIVES:

Specify and quantify morphological changes in key anatomical locations of the UA by computed tomography (CT), in terms of vertical lengths, volumes, areas, axial dimensions, and other measurements. These changes happen after MMA surgery in patients diagnosed with moderate-severe SAHS from a representative cohort. We are intended to demonstrate: shortening, increase in volume and areas, more elliptical and uniform shape, modifications of PST and SP and more anterior-superior hyoid bone position.

As secondary objectives, inherent to the treatment received, it is first intended to determine and evaluate clinical outcomes: objectively by polysomnography, and subjectively by the Epworth scale. Secondary, it is intended to specify and quantify changes in DCF morphology: objectively by a two-dimensional cephalometric analysis from lateral teleradiography of the cranium (LTC) and right face profile picture (RFP), and subjectively by a non-validated facial aesthetics test (FAT).

DESIGN:

Observational retrospective-prospective study, which does not make any modification of the usual clinical practice (surgical indication criteria, procedures, examinations, surgical techniques...), of: clinical outcomes, UA morphology, and DCF aspects of SAHS patients undergoing MMA.

  • Logistic and organizational process for the participants: Explanations, invitation to participate, resolution of doubts, delivery of written information sheet and informed consent, collection of them and FAT. Everything will be done in two face-to-face clinic consultations that are already part of the usual work protocol of the Maxillofacial Surgery department of our hospital for patients with SAHS. It is estimated that it only involves about 10-15 minutes per consultation of extra time, without the need of additional specific appointments for the present study. With regard to clinical history, complementary examinations and surgical procedure, nothing additional is required regarding the usual workflow for SAHS patients in our department.
  • Logistic and organizational process for researchers: It is based on office and digital work, without biological samples.

A sample size of 40 subjects is estimated, compiling previous studies and the Granmo® calculator. This would achieve significant statistics in all the parameters considered to answer the main hypothesis, and most of the secondary ones.

The Declaration of Helsinki code of medical ethics for research in human beings will be taken into account, protecting the health of the participant, being voluntary the inclusion, interrupting the investigation if it can be detrimental to the well-being of the participant and agreement of confidentiality in the IC. The "CEIC OSI Exkerraldea-Enkarterri-Cruces" committee has approved the study (Code CEIC E19/39).

DATA ANALYSIS:

We will analyze the qualitative and continuous quantitative variables in categorical variables. Descriptive statistics of frequencies will be calculated. For statistical inference, only comparisons are made between two continuous variables, all dependent and paired (pre- / post-). To verify that the variables follow a normal distribution, the Kolmogorov-Smirnov statistic will be used. The comparisons will then be made with the t-Student test for two dependent samples or the Wilcoxon ranks test if they do not follow a normal distribution. Statistically significant results will be considered if p ˂0.05.

Study Type

Observational

Enrollment (Actual)

38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bizkaia
      • Baracaldo, Bizkaia, Spain, 48903
        • Carlos Prol

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients treated in a single centre: Maxillofacial Surgery department, "Hospital de Cruces", Barakaldo, Spain Time period from 01/01/2012 to 01/31/2019.

Description

Inclusion Criteria:

  • ≥18 years-old.
  • Diagnosis by polysomnography of moderate-severe obstructive sleep apnoea / hypopnoea syndrome (SAHS) in supine position.
  • Approval of the surgical indication by the multidisciplinary sleep committee of our hospital
  • Written informed consent (IC) of photography or image recording, orthognathic surgery program inclusion and facial deformity surgery.
  • Specific IC for inclusion in the present study.

Exclusion Criteria:

  • Pregnant woman
  • Central SAHS
  • Medical-surgical history that significantly alter the normal upper-airway anatomy: trauma, tumour, major congenital craniofacial deformity
  • Different orthognathic surgery than MMA
  • Inconclusive / incomplete tests and data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Preoperative (Pre-)
Moderate-severe obstructive sleep apnoea / hypopnoea patients, preoperative
Maxilla: Lefort I osteotomy Mandible: Obwegeser-Dal-Pont osteotomy Movements: Advance and counterclockwise rotation
Other Names:
  • Bimaxillary Advancement
  • Orthognathic Surgery
Postoperative (Post-)
Moderate-severe obstructive sleep apnoea / hypopnoea patients, postoperative
Maxilla: Lefort I osteotomy Mandible: Obwegeser-Dal-Pont osteotomy Movements: Advance and counterclockwise rotation
Other Names:
  • Bimaxillary Advancement
  • Orthognathic Surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper-airway morphology: Vertical length
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Total, retropalatal compartment, retro-glossal compartment, hypopharynx compartment and summatory. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: volume
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Total, retropalatal compartment, retro-glossal compartment, hypopharynx compartment and summatory. Measured in mm^3.
Through study completion, an average of 1 year
Upper-airway morphology: area
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Minimum, hard palate plane, parallel uvula tip plane, parallel epiglottis tip plane, parallel inferior edge of the hyoid bone plane. Measured in mm. Measured in mm^2.
Through study completion, an average of 1 year
Upper-airway morphology: ellipticity
Time Frame: Through study completion, an average of 1 year
A formula: transversal dimension / anteroposterior dimension. Dimensions characteristics are: From computed-tomography examinations. Minimum, hard palate plane, parallel uvula tip plane, parallel epiglottis tip plane, parallel inferior edge of the hyoid bone plane. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: uniformity
Time Frame: Through study completion, an average of 1 year
A formula: minimum area / (hard palate area + uvula tip area + epiglottis tip area + hyoid bone area) Measured in units from 0 to 1.
Through study completion, an average of 1 year
Upper-airway morphology: prevertebral soft tissue length
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: soft palate length
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: position of the hyoid bone
Time Frame: Through study completion, an average of 1 year
From computed-tomography examinations. Measured in mm in the anteroposterior aspect and also the superoinferior aspect, this one is the same measure as vertical length.
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical outcomes: Apnoea / hypopnoea index
Time Frame: Through study completion, an average of 1 year
From polysomnography records. Global, in supine position and in lateral position. Measured in units from 0 to 100.
Through study completion, an average of 1 year
Clinical outcomes: pulse oximeter oxygen saturation.
Time Frame: Through study completion, an average of 1 year
From polysomnography records. Mean, basal and minimum. Measured in %.
Through study completion, an average of 1 year
Clinical outcomes: daytime sleepiness
Time Frame: Through study completion, an average of 1 year
From the Epworth scale. Measured in units from 0 to 24.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: facial axis angle
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: facial depth
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: mandibular plane angle
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: lower facial height
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: mandibular arch
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: facial convexity
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: maxillary depth
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: incisor protrusion
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: incisor inclination
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: incisor extrusion
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: interincisal angle
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in grades.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: upper molar position
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: labial protrusion
Time Frame: Through study completion, an average of 1 year
From lateral teleradiography of the cranium and right facial profile photography. Measured in mm.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: general satisfaction
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: none, little, ok, a lot of.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: modifications perceived by the patient
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: much worse, worse, no changes, better, much better.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: modifications perceived by family members and friends
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: much worse, worse, no changes, better, much better.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: smile
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: much worse, worse, no changes, better, much better.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: face rejuvenation
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: older, no changes, younger.
Through study completion, an average of 1 year
Dental-cranium-facial morphology: non-validated facial aesthetics test: face slimness
Time Frame: Through study completion, an average of 1 year
Qualitative measurement: bulkier, no changes, slimmer.
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carlos Prol, Mr, Osakidetza

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Anticipated)

November 30, 2021

Study Registration Dates

First Submitted

March 4, 2020

First Submitted That Met QC Criteria

March 5, 2020

First Posted (Actual)

March 10, 2020

Study Record Updates

Last Update Posted (Actual)

February 10, 2021

Last Update Submitted That Met QC Criteria

February 9, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

General non-identifying subjects data Upper-airway morphology data Clinical outcomes data Dental-cranium-facial morphology data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Craniofacial Abnormalities

Clinical Trials on Maxillo-mandibular Advancement + Counterclockwise rotation

Subscribe